Canada Sexually Transmitted Disease Testing Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Setting (Laboratory Testing and Point-of-Care (POC)), By Application (Chlamydia, Syphilis, Genital Herpes, Gonorrhea, Human Immunodeficiency Virus, Human Papillomavirus (HPV), Trichomonas Vaginalis, Mycoplasma Genitalium, Candida Vaginitis, Bacterial Vaginosis, and Others), By End-user (Independent Clinical Laboratories, Hospital-based Laboratories, Homecare Settings, and Others), and Country Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106798

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 4.3% from 2024 to 2032
Unit	Value (USD Million)
Segmentation	By Product Instruments Reagents & Kits
	By Setting Laboratory Testing Point-of-Care (POC)
	By Application Chlamydia Syphilis Genital Herpes Gonorrhea Human Immunodeficiency Virus Human Papillomavirus (HPV) Trichomonas Vaginalis Mycoplasma Genitalium Candida Vaginitis Bacterial Vaginosis Others
	By End-user Independent Clinical Laboratories Hospital-based Laboratories Homecare Settings Others